Nishimaki-Mogami T, Suzuki K, Takahashi A
National Institute of Health Sciences, Tokyo, Japan.
Biochim Biophys Acta. 1996 Nov 11;1304(1):21-31. doi: 10.1016/s0005-2760(96)00100-2.
The role of phosphatidylcholine (PC) synthesis via the phosphatidylethanolamine (PE) methylation pathway in the secretion of very low density lipoproteins (VLDL) by cultured rat hepatocytes has been investigated by determining the effects of inhibitors. We have shown that bezafibrate and clofibric acid, known hypolipidemic agents, are potent inhibitors of PE methylation (see accompanying paper by Nishimaki-Mogami et al. (1996) Biochim. Biophys. Acta 1304). In hepatocytes incubated with ethanolamine, which maintained cellular PE levels and PE methylation activity, bezafibrate (200 microM) decreased the secretion of triacylglycerol (TG), PC, apolipoproteins B48, and E in VLDL by 50-75%. In contrast, bezafibrate at this concentration had marginal effect on VLDL secretion (83-115% of control) by hepatocytes that had been cultured in the absence of ethanolamine. In these cells PE levels and PE methylation activity had decreased by approx. 40%. VLDL secretion was decreased at concentrations similar to those required to inhibit PE methylation, and was accompanied by an increase in cellular TG levels. The same ethanolamine-dependent effects were produced by clofibric acid and also by 3-deazaadenosine (DZA), an inhibitor of cellular methylation reactions. These results indicate that PC synthesis via the PE methylation pathway plays a significant role in VLDL secretion in rat hepatocytes if the pathway is maintained at levels comparable to those in vivo. The reductions of PE methylation by bezafibrate and DZA did not affect the total amount of apolipoprotein B48 secreted into the medium. The decrease in apolipoprotein B48 in VLDL caused by bezafibrate was accompanied by an increase in apolipoprotein B48 in the HDL density range. In contrast, the amount of apolipoprotein B100 in VLDL and density determined by sequential flotation were unaffected. These findings indicate that rapid reduction of PC synthesis via PE methylation does not affect the secretion of apolipoprotein B48- or B100-containing lipoprotein particles, but does impair the lipidation of particles containing apolipoprotein B48, but not apolipoprotein B100.
通过测定抑制剂的作用,研究了经由磷脂酰乙醇胺(PE)甲基化途径合成磷脂酰胆碱(PC)在培养的大鼠肝细胞分泌极低密度脂蛋白(VLDL)中的作用。我们已经表明,已知的降血脂药物苯扎贝特和氯贝酸是PE甲基化的有效抑制剂(见Nishimaki - Mogami等人(1996年)发表在《生物化学与生物物理学报》1304 上的随附论文)。在用乙醇胺孵育的肝细胞中,乙醇胺可维持细胞内PE水平和PE甲基化活性,苯扎贝特(200 microM)使VLDL中三酰甘油(TG)、PC、载脂蛋白B48和E的分泌减少了50 - 75%。相比之下,该浓度的苯扎贝特对在无乙醇胺条件下培养的肝细胞分泌VLDL的影响很小(为对照的83 - 115%)。在这些细胞中,PE水平和PE甲基化活性下降了约40%。VLDL分泌在与抑制PE甲基化所需浓度相似时降低,并且伴随着细胞内TG水平的升高。氯贝酸以及细胞甲基化反应抑制剂3 - 脱氮腺苷(DZA)也产生了相同的乙醇胺依赖性效应。这些结果表明,如果经由PE甲基化途径的PC合成维持在与体内相当的水平,那么它在大鼠肝细胞VLDL分泌中起重要作用。苯扎贝特和DZA对PE甲基化的降低并不影响分泌到培养基中的载脂蛋白B48的总量。苯扎贝特导致VLDL中载脂蛋白B48减少的同时,HDL密度范围内的载脂蛋白B48增加。相比之下,VLDL中载脂蛋白B100的量以及通过连续浮选测定的密度不受影响。这些发现表明,通过PE甲基化快速减少PC合成并不影响含载脂蛋白B48或B100的脂蛋白颗粒的分泌,但确实会损害含载脂蛋白B48而非载脂蛋白B100的颗粒的脂化。